title: Prostatodynia in United Nations peacekeeping forces in Haiti.
abstract: Prostatodynia is a clinical entity associated with voiding symptoms and pelvic pain suggestive of prostatitis but with a normal prostate examination and without evidence of inflammation or infection in expressed prostatic secretions. The problem tends to be chronic and is vexing in its management. Although thought to be a common condition, prevalence data are generally lacking. From June to October 1995, the U.S. Army's 86th Combat Support Hospital provided medical support to a multinational United Nations peacekeeping force in Haiti. Patients diagnosed with prostatodynia were more common (13 cases) than men with other urologic problems (urolithiasis, 6 cases; urinary tract infection, 6 cases; scrotal abscess/mass, 2 cases; epididymitis, 1 case). Patients tended to be young (mean age 29.8), had multiple visits, failed to respond to multiple courses of antibiotics for presumed "prostatitis," and denied recent sexual relations. Some patients reported having had similar symptoms on prolonged separation from their spouses in the past that resolved with resumption of normal intercourse. Masturbation, however, had no impact on symptoms and was painful in some individuals. Terazosin, an alpha-antagonist, and stress-reduction therapy led to improvement in some patients' symptoms. A discussion of these retrospective findings in light of what is known about the possible etiologies and treatment of prostatodynia is presented. Prostatodynia appears to be a common problem in deployed troops and can lead to frequent use of medical services. Physicians supporting long deployments need to be aware of this entity.
authors.affiliation: Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Drabick
authors.forename: J M
authors.initials: JM
authors.lastname: Gambel
authors.forename: J F
authors.initials: JF
authors.lastname: Mackey
mesh_terms: D000038:Abscess / Q000175:diagnosis; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003075:Coitus; D003937:Diagnosis, Differential; D004823:Epididymitis / Q000175:diagnosis; D005832:Genital Diseases, Male / Q000175:diagnosis / Q000382:microbiology; D006205:Haiti; D006801:Humans; D008297:Male; D008418:Masturbation / Q000503:physiopathology; D008875:Middle Aged; D008889:Military Personnel; D017699:Pelvic Pain / Q000175:diagnosis* / Q000517:prevention & control; D011224:Prazosin / Q000031:analogs & derivatives / Q000627:therapeutic use; D015995:Prevalence; D011469:Prostatic Diseases / Q000175:diagnosis* / Q000517:prevention & control; D011472:Prostatitis / Q000175:diagnosis / Q000188:drug therapy; D012189:Retrospective Studies; D012611:Scrotum / Q000382:microbiology; D013312:Stress, Physiological / Q000517:prevention & control; D014480:United Nations; D014545:Urinary Calculi / Q000175:diagnosis; D014552:Urinary Tract Infections / Q000175:diagnosis; D014555:Urination Disorders / Q000175:diagnosis
chemical_list: D000317:Adrenergic alpha-Antagonists; D000900:Anti-Bacterial Agents; C041226:Terazosin; D011224:Prazosin